• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗中性粒细胞胞浆抗体相关性血管炎患者的循环补体激活。

Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

机构信息

Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, China.

出版信息

Kidney Int. 2013 Jan;83(1):129-37. doi: 10.1038/ki.2012.313. Epub 2012 Aug 22.

DOI:10.1038/ki.2012.313
PMID:22913983
Abstract

Studies in animal models suggest that complement activation is crucial in the pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV). Here we investigate the circulating complement activation profile of 66 patients with active stage AAV compared to that of 54 patients with AAV in remission. Plasma levels of C3a, C5a, soluble C5b-9, and Bb, all determined by enzyme-linked immunosorbent assay, were significantly higher in active stage than in remission of AAV, while plasma levels of properdin were significantly lower in the former than the latter disease stage. There was no significant difference in the plasma levels of C4d between active stage and remission. The plasma level of Bb in patients with active AAV significantly correlated with the proportion of total and cellular crescents in the renal biopsy, the erythrocyte sedimentation rate, and the Birmingham Vasculitis Activity Scores. Thus, systemic activation of complement by the alternative pathway takes place in human AAV. Circulating Bb might be a useful biomarker in assessing disease activity of AAV.

摘要

研究动物模型表明,补体激活在抗中性粒细胞胞浆抗体相关性血管炎(AAV)的发病机制中至关重要。在这里,我们研究了 66 例活动期 AAV 患者与 54 例缓解期 AAV 患者的循环补体激活谱。通过酶联免疫吸附试验测定的 C3a、C5a、可溶性 C5b-9 和 Bb 的血浆水平在活动期 AAV 中明显高于缓解期,而前一疾病阶段的血浆水平 Properdin 明显低于后者。活动期与缓解期之间 C4d 的血浆水平无显著差异。活动期 AAV 患者的 Bb 血浆水平与肾活检中总新月体和细胞新月体的比例、红细胞沉降率和伯明翰血管炎活动评分显著相关。因此,旁路途径的系统性补体激活发生在人类 AAV 中。循环 Bb 可能是评估 AAV 疾病活动的有用生物标志物。

相似文献

1
Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎患者的循环补体激活。
Kidney Int. 2013 Jan;83(1):129-37. doi: 10.1038/ki.2012.313. Epub 2012 Aug 22.
2
Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.检测髓过氧化物酶和蛋白酶 3 抗中性粒细胞胞质抗体相关性血管炎中的循环补体激活产物。
Arthritis Rheumatol. 2019 Nov;71(11):1894-1903. doi: 10.1002/art.41011. Epub 2019 Oct 8.
3
Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis.血浆补体因子H与抗中性粒细胞胞浆抗体相关性血管炎患者的疾病活动相关。
Arthritis Res Ther. 2015 May 21;17(1):129. doi: 10.1186/s13075-015-0656-8.
4
Neutrophil extracellular traps can activate alternative complement pathways.中性粒细胞胞外诱捕网可激活替代补体途径。
Clin Exp Immunol. 2015 Sep;181(3):518-27. doi: 10.1111/cei.12654. Epub 2015 Jun 22.
5
Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.抗中性粒细胞胞质抗体相关性肾小球肾炎患者尿液和肾脏中补体替代途径激活产物。
Clin J Am Soc Nephrol. 2013 Nov;8(11):1884-91. doi: 10.2215/CJN.02790313. Epub 2013 Oct 10.
6
Complement is crucial in the pathogenesis of ANCA-associated vasculitis.补体在抗中性粒细胞胞质抗体相关性血管炎的发病机制中至关重要。
Kidney Int. 2013 Jan;83(1):16-8. doi: 10.1038/ki.2012.371.
7
Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.高迁移率族蛋白 B1 循环水平与抗中性粒细胞胞浆自身抗体相关性血管炎疾病活动的相关性。
Arthritis Care Res (Hoboken). 2013 Nov;65(11):1828-34. doi: 10.1002/acr.22187.
8
Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.抗中性粒细胞胞浆抗体相关肾血管炎患者血清C3浓度及血栓性微血管病组织学表现与预后的关系
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2143-51. doi: 10.2215/CJN.00120115. Epub 2015 Nov 5.
9
C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.C5a 及其受体在人类抗中性粒细胞胞浆抗体(ANCA)相关性血管炎中的作用。
Arthritis Res Ther. 2012 Jun 12;14(3):R140. doi: 10.1186/ar3873.
10
Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.在小血管血管炎患者的循环中,中性粒细胞胞外诱捕网残余物的水平增加,但在缓解期与抗中性粒细胞胞浆抗体呈负相关。
Rheumatology (Oxford). 2015 Nov;54(11):2085-94. doi: 10.1093/rheumatology/kev217. Epub 2015 Jul 12.

引用本文的文献

1
Avacopan is effective in inducing remission for MPA/GPA, regardless of changes in serum C5a levels: a single-center study in Japan.阿伐库潘对显微镜下多血管炎/肉芽肿性多血管炎诱导缓解有效,无论血清C5a水平如何变化:日本一项单中心研究
BMC Rheumatol. 2025 Aug 11;9(1):99. doi: 10.1186/s41927-025-00555-2.
2
The complement system in autoimmune diseases: pathogenesis, diagnostic markers, and therapeutic strategies.自身免疫性疾病中的补体系统:发病机制、诊断标志物及治疗策略。
Inflamm Res. 2025 Jun 30;74(1):93. doi: 10.1007/s00011-025-02061-0.
3
Advances in the treatment of ANCA-associated vasculitis.
抗中性粒细胞胞浆抗体相关血管炎的治疗进展
Nat Rev Rheumatol. 2025 Jun 5. doi: 10.1038/s41584-025-01266-1.
4
Complement factors as biomarkers in ANCA-associated vasculitis in remission.补体因子作为缓解期抗中性粒细胞胞浆抗体相关性血管炎的生物标志物。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf037.
5
Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation.C4d与抗中性粒细胞胞浆抗体相关血管炎疾病活动的关联:经典/凝集素补体途径激活的证据
Arthritis Res Ther. 2025 Mar 5;27(1):49. doi: 10.1186/s13075-025-03503-0.
6
ANCA-Associated Glomerulonephritis: Diagnosis and Therapy Proceedings of the Henry Shavelle Lectureship.抗中性粒细胞胞浆抗体相关性肾小球肾炎:亨利·沙韦勒讲座系列之诊断与治疗
Glomerular Dis. 2024 Dec 2;5(1):26-47. doi: 10.1159/000542925. eCollection 2025 Jan-Dec.
7
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook.中国抗中性粒细胞胞浆抗体相关性血管炎:流行病学、管理、预后及展望
Kidney Dis (Basel). 2024 Aug 5;10(5):407-420. doi: 10.1159/000540514. eCollection 2024 Oct.
8
Complement as a major mediator of ANCA vasculitis and a target for precision therapy.补体作为抗中性粒细胞胞浆抗体相关性血管炎的主要介质及精准治疗靶点。
Expert Rev Clin Immunol. 2025 Jan;21(1):45-53. doi: 10.1080/1744666X.2024.2405170. Epub 2024 Sep 18.
9
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome.寡免疫性新月体肾小球肾炎中的肾衰竭:免疫抑制改善肾脏预后的理由。
Curr Rheumatol Rep. 2024 Aug;26(8):290-301. doi: 10.1007/s11926-024-01150-z. Epub 2024 May 6.
10
ANCA-Associated Vasculitis with Systemic Thrombotic Microangiopathy: A Review of Literature.伴有系统性血栓性微血管病的抗中性粒细胞胞浆抗体相关性血管炎:文献综述
Indian J Nephrol. 2024 Mar-Apr;34(2):155-161. doi: 10.4103/ijn.ijn_376_22. Epub 2023 Oct 23.